Biosite Incorporated

92 articles about Biosite Incorporated

• Biosite Incorporated's Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage

  4/26/2010

• CDRH Updates: Biosite Incorporated Class I Medical Device Recall: Triage Cardiac Panel

  5/11/2009

• Biosite Incorporated Issues Voluntary, Nationwide Recall for Cardiac Marker Test

  5/6/2009

• Adnavance Technologies Inc. Appoints Biosite Incorporated Co-Founder Kenneth Buechler, Ph.D., to its Board of Directors

  4/10/2008

• Compugen Ltd. Discloses Novel Troponin Variant for Identification of Cardiac Muscle Injury, Receipt of Patent for the Molecule and Collaboration with Biosite Incorporated

  4/1/2008

• Merger Restructuring Hits Diagnostics Maker Biosite Incorporated (Jobs): Cutting 107 Employees

  8/24/2007

• Inverness Medical Innovations, Inc. Completes Acquisition of Biosite Incorporated

  6/29/2007

• Inverness Medical Innovations, Inc. Announces Successful Completion of Tender Offer for Biosite Incorporated

  6/26/2007

• Inverness Medical Innovations, Inc. and Biosite Incorporated Announce Expiration of Hart-Scott-Rodino Waiting Period

  6/7/2007

• Inverness Medical Innovations, Inc. Commences Cash Tender Offer for Biosite Incorporated at $92.50 Per Share

  5/29/2007

• Beckman Coulter, Inc. Extends Cash Tender Offer to Conform to Expected Termination Date of Its Revised Merger Agreement With Biosite Incorporated

  5/16/2007

• Biosite Incorporated Determines That Revised Binding Offer From Inverness Medical Innovations, Inc. Constitutes a 'Superior Proposal'

  5/15/2007

• Beckman Coulter, Inc. Advises It Will Not Increase Its Offer to Acquire Biosite Incorporated Beyond $90.00 Per Share

  5/15/2007

• Biosite Incorporated Prepared to Enter Into Discussions With Inverness Medical Innovations, Inc.

  5/11/2007

• Inverness Medical Innovations, Inc. Announces Binding Offer to Acquire Biosite Incorporated via Cash Tender at $92.50 Per Share

  5/10/2007

• Biosite Incorporated Receives Revised Offer From Inverness Medical Innovations, Inc. Regarding Possible Cash Tender Offer

  5/10/2007

• Biosite Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350

  5/3/2007

• Beckman Coulter, Inc. and Biosite Incorporated Amend Definitive Acquisition Agreement

  5/2/2007

• Inverness Medical Innovations, Inc. Confirms Binding Offer To Acquire Biosite Incorporated for $90 Per Share in Cash

  4/26/2007

• Beckman Coulter, Inc. Acknowledges Receipt of Notice from Biosite Incorporated

  4/26/2007